VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 41 filers reported holding VERONA PHARMA PLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,074,190 | -87.1% | 381,939 | -87.8% | 1.14% | -89.5% |
| Q1 2023 | $62,798,774 | -16.4% | 3,127,429 | +8.8% | 10.80% | -9.4% |
| Q4 2022 | $75,137,494 | +174.4% | 2,875,526 | +7.3% | 11.92% | +147.7% |
| Q3 2022 | $27,379,000 | +605.3% | 2,678,982 | +189.1% | 4.81% | +442.0% |
| Q2 2022 | $3,882,000 | -16.0% | 926,602 | 0.0% | 0.89% | -18.8% |
| Q1 2022 | $4,624,000 | -25.7% | 926,602 | 0.0% | 1.09% | -46.8% |
| Q4 2021 | $6,227,000 | +22.6% | 926,602 | 0.0% | 2.05% | +11.2% |
| Q3 2021 | $5,078,000 | +825.0% | 926,602 | +1003.8% | 1.85% | +717.3% |
| Q2 2021 | $549,000 | -21.8% | 83,944 | 0.0% | 0.23% | -23.6% |
| Q1 2021 | $702,000 | +0.3% | 83,944 | -16.1% | 0.30% | +18.4% |
| Q4 2020 | $700,000 | +12.2% | 100,000 | 0.0% | 0.25% | -5.3% |
| Q3 2020 | $624,000 | – | 100,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |